GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates

16 Apr 2024 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received be request for issue of duplicate Share Certificates from Shareholders, Ramaniklal Amarprasad Passawala; Suryakanta Ramaniklal Passawala (Folio No: 0156028), further details attached. 

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×